Greater absolute risk for all subtypes of breast cancer in the US than Malaysia

Hisani N. Horne, C. R. Beena Devi, Hyuna Sung, Tieng Swee Tang, Philip S. Rosenberg, Stephen M. Hewitt, Mark E. Sherman, William F. Anderson, Xiaohong R. Yang

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Hormone receptor (HR) negative breast cancers are relatively more common in low-risk than high-risk countries and/or populations. However, the absolute variations between these different populations are not well established given the limited number of cancer registries with incidence rate data by breast cancer subtype. We, therefore, used two unique population-based resources with molecular data to compare incidence rates for the ‘intrinsic’ breast cancer subtypes between a low-risk Asian population in Malaysia and high-risk non-Hispanic white population in the National Cancer Institute’s surveillance, epidemiology, and end results 18 registries database (SEER 18). The intrinsic breast cancer subtypes were recapitulated with the joint expression of the HRs (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor-2 (HER2). Invasive breast cancer incidence rates overall were fivefold greater in SEER 18 than in Malaysia. The majority of breast cancers were HR-positive in SEER 18 and HR-negative in Malaysia. Notwithstanding the greater relative distribution for HR-negative cancers in Malaysia, there was a greater absolute risk for all subtypes in SEER 18; incidence rates were nearly 7-fold higher for HR-positive and 2-fold higher for HR-negative cancers in SEER 18. Despite the well-established relative breast cancer differences between low-risk and high-risk countries and/or populations, there was a greater absolute risk for HR-positive and HR-negative subtypes in the US than Malaysia. Additional analytical studies are sorely needed to determine the factors responsible for the elevated risk of all subtypes of breast cancer in high-risk countries like the United States.

Original languageEnglish (US)
Pages (from-to)285-291
Number of pages7
JournalBreast Cancer Research and Treatment
Volume149
Issue number1
DOIs
StatePublished - 2015

Fingerprint

Malaysia
Breast Neoplasms
Hormones
Registries
Epidemiology
Databases
Population
Incidence
Neoplasms
National Cancer Institute (U.S.)
Progesterone Receptors
Estrogen Receptors
Joints

Keywords

  • Breast cancer
  • Incidence rates
  • Intrinsic subtypes
  • SEER

ASJC Scopus subject areas

  • Oncology
  • Cancer Research
  • Medicine(all)

Cite this

Horne, H. N., Beena Devi, C. R., Sung, H., Tang, T. S., Rosenberg, P. S., Hewitt, S. M., ... Yang, X. R. (2015). Greater absolute risk for all subtypes of breast cancer in the US than Malaysia. Breast Cancer Research and Treatment, 149(1), 285-291. https://doi.org/10.1007/s10549-014-3243-9

Greater absolute risk for all subtypes of breast cancer in the US than Malaysia. / Horne, Hisani N.; Beena Devi, C. R.; Sung, Hyuna; Tang, Tieng Swee; Rosenberg, Philip S.; Hewitt, Stephen M.; Sherman, Mark E.; Anderson, William F.; Yang, Xiaohong R.

In: Breast Cancer Research and Treatment, Vol. 149, No. 1, 2015, p. 285-291.

Research output: Contribution to journalArticle

Horne, HN, Beena Devi, CR, Sung, H, Tang, TS, Rosenberg, PS, Hewitt, SM, Sherman, ME, Anderson, WF & Yang, XR 2015, 'Greater absolute risk for all subtypes of breast cancer in the US than Malaysia', Breast Cancer Research and Treatment, vol. 149, no. 1, pp. 285-291. https://doi.org/10.1007/s10549-014-3243-9
Horne, Hisani N. ; Beena Devi, C. R. ; Sung, Hyuna ; Tang, Tieng Swee ; Rosenberg, Philip S. ; Hewitt, Stephen M. ; Sherman, Mark E. ; Anderson, William F. ; Yang, Xiaohong R. / Greater absolute risk for all subtypes of breast cancer in the US than Malaysia. In: Breast Cancer Research and Treatment. 2015 ; Vol. 149, No. 1. pp. 285-291.
@article{e7e6a76808164650b52f95ffb3b34026,
title = "Greater absolute risk for all subtypes of breast cancer in the US than Malaysia",
abstract = "Hormone receptor (HR) negative breast cancers are relatively more common in low-risk than high-risk countries and/or populations. However, the absolute variations between these different populations are not well established given the limited number of cancer registries with incidence rate data by breast cancer subtype. We, therefore, used two unique population-based resources with molecular data to compare incidence rates for the ‘intrinsic’ breast cancer subtypes between a low-risk Asian population in Malaysia and high-risk non-Hispanic white population in the National Cancer Institute’s surveillance, epidemiology, and end results 18 registries database (SEER 18). The intrinsic breast cancer subtypes were recapitulated with the joint expression of the HRs (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor-2 (HER2). Invasive breast cancer incidence rates overall were fivefold greater in SEER 18 than in Malaysia. The majority of breast cancers were HR-positive in SEER 18 and HR-negative in Malaysia. Notwithstanding the greater relative distribution for HR-negative cancers in Malaysia, there was a greater absolute risk for all subtypes in SEER 18; incidence rates were nearly 7-fold higher for HR-positive and 2-fold higher for HR-negative cancers in SEER 18. Despite the well-established relative breast cancer differences between low-risk and high-risk countries and/or populations, there was a greater absolute risk for HR-positive and HR-negative subtypes in the US than Malaysia. Additional analytical studies are sorely needed to determine the factors responsible for the elevated risk of all subtypes of breast cancer in high-risk countries like the United States.",
keywords = "Breast cancer, Incidence rates, Intrinsic subtypes, SEER",
author = "Horne, {Hisani N.} and {Beena Devi}, {C. R.} and Hyuna Sung and Tang, {Tieng Swee} and Rosenberg, {Philip S.} and Hewitt, {Stephen M.} and Sherman, {Mark E.} and Anderson, {William F.} and Yang, {Xiaohong R.}",
year = "2015",
doi = "10.1007/s10549-014-3243-9",
language = "English (US)",
volume = "149",
pages = "285--291",
journal = "Breast Cancer Research and Treatment",
issn = "0167-6806",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Greater absolute risk for all subtypes of breast cancer in the US than Malaysia

AU - Horne, Hisani N.

AU - Beena Devi, C. R.

AU - Sung, Hyuna

AU - Tang, Tieng Swee

AU - Rosenberg, Philip S.

AU - Hewitt, Stephen M.

AU - Sherman, Mark E.

AU - Anderson, William F.

AU - Yang, Xiaohong R.

PY - 2015

Y1 - 2015

N2 - Hormone receptor (HR) negative breast cancers are relatively more common in low-risk than high-risk countries and/or populations. However, the absolute variations between these different populations are not well established given the limited number of cancer registries with incidence rate data by breast cancer subtype. We, therefore, used two unique population-based resources with molecular data to compare incidence rates for the ‘intrinsic’ breast cancer subtypes between a low-risk Asian population in Malaysia and high-risk non-Hispanic white population in the National Cancer Institute’s surveillance, epidemiology, and end results 18 registries database (SEER 18). The intrinsic breast cancer subtypes were recapitulated with the joint expression of the HRs (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor-2 (HER2). Invasive breast cancer incidence rates overall were fivefold greater in SEER 18 than in Malaysia. The majority of breast cancers were HR-positive in SEER 18 and HR-negative in Malaysia. Notwithstanding the greater relative distribution for HR-negative cancers in Malaysia, there was a greater absolute risk for all subtypes in SEER 18; incidence rates were nearly 7-fold higher for HR-positive and 2-fold higher for HR-negative cancers in SEER 18. Despite the well-established relative breast cancer differences between low-risk and high-risk countries and/or populations, there was a greater absolute risk for HR-positive and HR-negative subtypes in the US than Malaysia. Additional analytical studies are sorely needed to determine the factors responsible for the elevated risk of all subtypes of breast cancer in high-risk countries like the United States.

AB - Hormone receptor (HR) negative breast cancers are relatively more common in low-risk than high-risk countries and/or populations. However, the absolute variations between these different populations are not well established given the limited number of cancer registries with incidence rate data by breast cancer subtype. We, therefore, used two unique population-based resources with molecular data to compare incidence rates for the ‘intrinsic’ breast cancer subtypes between a low-risk Asian population in Malaysia and high-risk non-Hispanic white population in the National Cancer Institute’s surveillance, epidemiology, and end results 18 registries database (SEER 18). The intrinsic breast cancer subtypes were recapitulated with the joint expression of the HRs (estrogen receptor and progesterone receptor) and human epidermal growth factor receptor-2 (HER2). Invasive breast cancer incidence rates overall were fivefold greater in SEER 18 than in Malaysia. The majority of breast cancers were HR-positive in SEER 18 and HR-negative in Malaysia. Notwithstanding the greater relative distribution for HR-negative cancers in Malaysia, there was a greater absolute risk for all subtypes in SEER 18; incidence rates were nearly 7-fold higher for HR-positive and 2-fold higher for HR-negative cancers in SEER 18. Despite the well-established relative breast cancer differences between low-risk and high-risk countries and/or populations, there was a greater absolute risk for HR-positive and HR-negative subtypes in the US than Malaysia. Additional analytical studies are sorely needed to determine the factors responsible for the elevated risk of all subtypes of breast cancer in high-risk countries like the United States.

KW - Breast cancer

KW - Incidence rates

KW - Intrinsic subtypes

KW - SEER

UR - http://www.scopus.com/inward/record.url?scp=84925511073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925511073&partnerID=8YFLogxK

U2 - 10.1007/s10549-014-3243-9

DO - 10.1007/s10549-014-3243-9

M3 - Article

C2 - 25537643

AN - SCOPUS:84925511073

VL - 149

SP - 285

EP - 291

JO - Breast Cancer Research and Treatment

JF - Breast Cancer Research and Treatment

SN - 0167-6806

IS - 1

ER -